Hadzhiolova T, Pavlova S, Kotseva R
Department of Virology, National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria.
Euro Surveill. 2008 Jul 24;13(30):18938.
Reports of human cases of infection with avian influenza A(H5N1) virus have received increased public attention because of the potential for the emergence of a pandemic strain. In the end of 2005 and the beginning of 2006, avian influenza A(H5N1) virus caused outbreaks among domestic poultry and was isolated from wild swans in many European countries, including Bulgaria. Between January and March 2006, samples were collected from 26 patients who had been in close contact with ill or dead birds and developed a subsequent respiratory illness. The testing took place at the National Laboratory of Influenza in Sofia. Specific A(H5N1) assays were applied for screening (Sacace RT-PCR and real-time kit). Avian flu A(H5N1) virus was not detected in any of the patients tested. In three patients, human subtype A(H1N1) influenza virus, identifiable by RT-PCR was isolated and further characterized by hemagglutination inhibition test (HIT). The reliability of the molecular assays used in this investigation was demonstrated in an International Quality Control for Human and Avian A(H5N1) Influenza performed later in 2006 by INSTAND (Society for Promotion of Quality Assurance in the Medical Laboratories), Germany.
由于可能出现大流行毒株,甲型H5N1禽流感病毒感染人类病例的报告受到了公众更多关注。在2005年底和2006年初,甲型H5N1禽流感病毒在家禽中引发疫情,并在包括保加利亚在内的许多欧洲国家从野生天鹅中分离出来。2006年1月至3月期间,从26名与病禽或死禽密切接触且随后出现呼吸道疾病的患者身上采集了样本。检测在索非亚的国家流感实验室进行。采用特定的甲型H5N1检测方法进行筛查(Sacace逆转录聚合酶链反应和实时检测试剂盒)。在接受检测的任何患者中均未检测到甲型H5N1禽流感病毒。在三名患者中,通过逆转录聚合酶链反应鉴定出人类甲型H1N1流感病毒,并通过血凝抑制试验进一步鉴定其特征。2006年晚些时候,德国INSTAND(医学实验室质量保证促进协会)进行的人类和禽甲型H5N1流感国际质量控制证明了本研究中使用的分子检测方法的可靠性。